COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead Our Letter to Patients
Podcast: Mark Hill on Digital Transformation
On our podcast, CSL’s Chief Digital Information Officer discusses how technology will continue to transform biotech.
Donating Plasma After Getting a COVID-19 Vaccine
Yes, you can still donate “source plasma” after being vaccinated.
Industry Partnership Fuels Research, Advocacy
PhRMA membership expands CSL Behring’s opportunity for cooperation between industry leaders.
COVID-19 Vaccines and Hemophilia Patients
Four hemophilia organizations issue a joint statement saying patients can get the COVID-19 vaccine and offering guidance on h…
A Day of Service and Reflection
Amid a continuing pandemic, here’s how we’re honoring the legacy of Martin Luther King Jr. in 2021.
Science Emoji and the Pandemic
Because of COVID-19, for the first time, the microbe emoji soared in popularity and in March featured in one out of every 50…
Working in Switzerland: Michael Bieri
A CSL Behring leader in advanced methodologies and innovation talks about his work life and how collaboration took “a big ste…
Innovating With Engineering Students
CSL Behring in Kankakee, Illinois, partners with local university to optimize the recovery of alcohol used in manufacturing.